Viewing StudyNCT05242146



Ignite Creation Date: 2024-05-06 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 2:25 PM
Study NCT ID: NCT05242146
Status: TERMINATED
Last Update Posted: 2023-06-13
First Post: 2022-01-31

Brief Title: GB5121 in Adult Patients With RelapsedRefractory CNS Lymphoma
Sponsor: GB005 Inc a wholly owned subsidiary of Gossamer Bio Inc
Organization: Gossamer Bio Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-24
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-11
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-11
Completion Date Type: ACTUAL
First Submit Date: 2022-01-31
First Submit QC Date: February 15 2022
Study First Post Date: 2022-02-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-12
Last Update Post Date: 2023-06-13
Last Update Post Date Type: ACTUAL